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To Editor:
Haemoglobin (Hb) is the oxygen-carrying moiety of
erythrocytes. It is a polypeptide tetramer consisting of two
pairs of unlike globin chains (α plus β, δ, or γ), which form a
shell around a central cavity containing four oxygen-binding
haeme groups; each covalently linked to a globin chain. In
healthy adults, ~  95% of the Hb is A (α2β2) with small amounts
of HbA2 (α2δ ) and HbF (α2γ2) present. The α-globin gene
is encoded in duplicate on chromosome 16, and the non-α
chains (β , δ , γ) are encoded in a cluster on chromosome 11.1
Alpha thalassaemia (α-thal) represents a heterogeneous
group of clinical conditions characterised by reduction or
suppression in synthesis of the α-globin chain, resulting in
the formation of erythrocytes with an inadequate content of
Hb and, therefore, microcytic and hypochromic. The
imbalance between the synthesis of  α- and  β-globin chains
in adults results in the accumulation of β-globin chains, which
are produced in a normal rhythm. The excess  β-globin chains
are unstable and precipitate intracellularly, causing alterations
in the membrane and cellular metabolism, that result, in the
destruction of the erythroblasts in the bone marrow
(ineffective erythropoiesis) or spleen (haemolysis) and
anaemia. 2-5
α-thal is caused particularly by an inherited deletion of
the  α-globin genes and its clinical severity is determined by
the number of inherited genes. Patients with two or three alpha
genes do not present symptoms and are only identified with
certainty, by molecular analysis. Three alpha gene deletions
lead to a moderately to severe microcytic, hypochromic anaemia
with splenomegaly, which is frequently erroneously treated
with iron compounds and red blood cell transfusion. This form
of α-thal is known as Hb H disease, since Hb (β4) can be
detected in erythrocyte preparations stained with brilliant
cresyl blue or electrophoresis of Hb.2-5 The loss of all α-genes
leads to death in the uterus (hydrops fetalis).2-4
The diagnostic definition of this illness is, in general,
confirmed by molecular studies, where the most usual are the
Mediterranean deletions (loss of two alleles of the same
chromosome) in Caucasians and 3.7 deletion (loss of one out
of two alleles of the same chromosome) in African
descendents.6-8
Herein, we present for educational purposes, the case
of a patient attended in our clinic and diagnosed with Hb H
disease, who had received erroneous treatment for anaemia
in other services.
The patient was a 50-year-old medium-brunette female
referred to our unit due to weakness, mucosal cutaneous pallor
and jaundice over 30 years. She had received treatment with
red blood cell transfusion and oral iron compounds sporadically
during her life. Mucosal cutaneous pallor, hepatomegaly and
splenomegaly were identified during the physical examination.
At this time, the peripheral blood examination showed:
RBC: 4.8x106/ µL, Hb: 8.5g/dL, MCV: 67.8 fL, MCH: 18.8 pg,
MCHC: 27.7g/dL, RDW: 22.5%, reticulocytes: 130.1x106/µL,
WBC: 4.6x103/µL, and Platelets: 132.0x103/µl. Hypochromic,
microcytic cells with target cells and poikilocytosis were
seen on the peripheral blood film (Figure 1). Serum iron:
123.0 µg/dL (normal: 49.0 to 151.0 µg/dL), TIBC: 244.0 (nor-
mal: 30.0 to 160.0 mcg/dL) and ferritin: 860.0 ng/mL (normal:
10.0 to 200.0 ng/mL). BT: 0.9 mg/dL (normal: < 1.0 mg/dL),
BD: 0.2 mg/dL (normal: < 0.2 mg/dL), BI: 0.70 mg/dL (nor-
mal: < 0.8 mg/dL), and haptoglobin: < 5.8 mg/dL (normal:
Figura 1. Peripheral blood film in haemoglobin H disease showing
hypochromic, microcytic cells with target cells and poikilocytosis
(Romanovsky, 100x)
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Figura 2. Peripheral blood film of haemoglobin H disease stained
supravitally with brilliant cresyl blue (x100). Numerous red blood
cells show multiple fine, deeply stained deposits that are precipitated
β-globin chain aggregates (golf-ball cells). Reticulocytes are also
stained
Figura 3. Electrophoresis gel of the normal control (Lane 1) showing
haemoglobin A (Hb A) and the haemoglobin H disease patient (Lane
2) showing Hb A and Hb H
Figura 4. Ethidium bromide-stained 2% agarose gel showing
polymerase chain reaction products of haemoglobin H disease
patient. (A) - Lane M: DNA size marker (∅ X-174-HaeIII), Lane 1:
Mediterranean deletion of alpha alleles is indicated by the 0.65-Kb
fragment, Lane 2: normal fragment. (B) - Lane M: DNA size marker
(λ Hind III), Lane 1: normal fragment of 2.1-Kb, Lane 2: 3.7 deletion
of alpha allele is indicated by the 1.9-Kb fragment
30.0 to 230.0 mg/dL). Peripheral blood smears stained with
brilliant cresyl blue revealed multiple fine, deeply stained
deposits caused by the precipitation of  β-globin chain
aggregates (golf-ball cells) (Figure 2), suggesting the presence
of Hb H.9
Electrophoresis of Hb showed Hb A2 + Hb A + Hb H.
Hb A2: 1.3% (normal: 1.5 to 3.5%), Hb F: 1.1% (normal: <
2.0%) and Hb H: 9.7% (Figure 3). Mediterranean deletion
and the 3.7 deletion were demonstrated by molecular studies7,8
(Figure 4).
The patient received the diagnosis of Hb H disease
and received 5 mg of folic acid orally per day as therapy.
In addition, she was advised to avoid therapies with iron
compounds or red blood cell transfusion and to direct
members of her family to our service for genetic counselling.
Resumo
A talassemia alfa é uma doença hereditária devida aos genes alfa  e
sua gravidade depende do número de genes compromtidos. Neste
relato apresentamos um caso em que originalmente não havia sido
realizado e descrevemos os resultados e os métodos adequados
para sua elucidação.
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